Cardiovascular diseases have become the leading cause of death worldwide. The
increasing burden of cardiovascular diseases has become a major public health problem …

Cardiovascular defects, injuries, and degenerative diseases often require surgical
intervention and the use of implantable replacement material and conduits. Traditional …

Vascular regeneration and patency maintenance, without anticoagulant administration,
represent key developmental trends to enhance small-diameter vascular grafts (SDVG) …

Vascular tissue engineering has made prodigious progress in recent years by converging
multidisciplinary approaches. Latest technological advancements foster the development of …

Congenital and acquired valvular heart diseases (VHDs) are significant causes of mortality
worldwide. With valve replacement being the primary solution for VHD, current options …

Small-diameter artificial vascular grafts (SDAVG) are used to bypass blood flow in arterial
occlusive diseases such as coronary heart or peripheral arterial disease. However, SDAVGs …

Despite the considerable advancements in fabricating polymeric-based scaffolds for tissue
engineering, the clinical transformation of these scaffolds remained a big challenge because …

Vascular bypass surgery continues to use autologous grafts and often suffers from a
shortage of donor grafts. Decellularized xenografts derived from porcine veins provide a …

Thrombosis and stenosis remain two of the most prevalent complications of vascular
implants. The most effective strategy in clinics to inhibit stenosis is based on the eluting of …

Implantation of vascular stents, with particular reference to drug-eluting stents (DESs), is
considered the main tool in treating coronary artery diseases (CADs) and has saved millions …